市場調查報告書
商品編碼
1287582
心臟結構成像市場:2023-2028年全球行業趨勢、佔有率、規模、成長、機會和預測Structural Heart Imaging Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028 |
2022年,全球心臟結構成像市場規模達到179億美元。展望未來,IMARC集團預計,到2028年,市場規模將達到322億美元,在2023-2028年期間表現出10.2%的成長率(CAGR)。
心臟結構成像(SHI)是一種特殊的技術,廣泛部署在醫療保健行業,在分子水平上篩查和檢查心臟。該程序包括利用光反射來產生內部元素圖像,並創建2D截面分析,以獲得明確和準確的診斷。還用來幫助專業人員進行各種手術,如透過減少干擾的風險來定位堵塞物和插入的路徑。
各種先天性、心臟疾病和生活方式引起的疾病,如肥胖、糖尿病和因過度飲酒和不健康的飲食習慣引起的高血壓的流行率不斷上升,是主要推動全球心臟成像市場成長的主要因素之一。此外,消費者健康意識的提高也對全球市場產生了積極的影響。除此之外,在高精度和高解析度的相機和感測器的支援下,廣泛採用SHI來解決各種心臟疾病,如非瓣膜性和瓣膜性心臟疾病,也大大促進了市場的成長。此外,經導管主動脈瓣置換術(TAVR)的引進,透過確保消費者在手術後的即時恢復來進行心臟病干預,促進市場的成長。除此之外,為引進先進的心臟結構成像和心臟系統而進行的研究和開發(R&D)活動的投資不斷增加,為市場創造積極的前景。同時,各國政府為改善醫療基礎設施以確保患者健康而採取的眾多計劃也進一步推動了市場的發展。
The global structural heart imaging market size reached US$ 17.9 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 32.2 Billion by 2028, exhibiting a growth rate (CAGR) of 10.2% during 2023-2028.
Structural heart imaging (SHI) is a special technique, which is extensively deployed in the healthcare industry for screening and examining the heart at the molecular level. This procedure includes the utilization of light reflection for producing the interior element images and creating a 2-dimensional cross-section analysis to get a clarified and accurate diagnosis. It is further used for enabling and assisting professionals while performing various operative procedures, such as locating the blockages and pathways for insertion by minimizing the risk of interference.
The escalating prevalence of various congenital, cardiac diseases and lifestyle-induced ailments, such as obesity, diabetes, and high blood pressure due to excessive alcohol consumption and unhealthy eating habits, is one of the primary factors majorly driving the global heart imaging market toward the growth. Furthermore, the rising health consciousness amongst the consumers is positively influencing the market across the globe. In addition to this, the widespread adoption of SHI for addressing various heart conditions, such as non-valvular and valvular heart diseases, with the support of high precision and resolution cameras and sensors is considerably contributing to the market growth. Moreover, the introduction of transcatheter aortic valve replacement (TAVR) for operating heart diseases interventions by ensuring instant recovery of consumers post-surgery is promoting the growth of the market. Other than this, the rising investments in research and development (R&D) activities for introducing advanced structural heart imaging and cardiac systems is creating a positive outlook for the market. In line with this, the market is further being driven by the numerous initiatives undertaken by the governments of various nations for improving the healthcare infrastructure to ensure patients wellness.
IMARC Group provides an analysis of the key trends in each sub-segment of the global structural heart imaging market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on imaging modality, procedure type, application and end user.
Echocardiogram
Angiogram
CT
MRI
Transcatheter Aortic Valve Replacement (TAVR)
Surgical Aortic Valve Replacement (SAVR)
Transcatheter Mitral Valve Repair (TMVR)
Left Atrial Appendage Closure (LAAC)
Annuloplasty
Valvuloplasty
Others
Diagnosis
Surgery
Hospitals
Specialty Clinics
Cardiac Centers
Diagnostic Centers
Ambulatory Surgical Centers
Catheterization Laboratories
Others
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, Boston Scientific Corporation, Circle Cardiovascular Imaging Inc., Edwards Lifesciences Corporation, Integer Holdings Corporation, Koninklijke Philips N.V., Lepu Medical Technology (Beijing) Co. Ltd., LivaNova PLC, Medtronic plc, Pie Medical Imaging B.V. and Siemens Healthcare GmbH.
Key Questions Answered in This Report
1. What was the size of the global structural heart imaging market in 2022?
2. What is the expected growth rate of the global structural heart imaging market during 2023-2028?
3. What are the key factors driving the global structural heart imaging market?
4. What has been the impact of COVID-19 on the global structural heart imaging market?
5. What is the breakup of the global structural heart imaging market based on the imaging modality?
6. What are the key regions in the global structural heart imaging market?
7. Who are the key players/companies in the global structural heart imaging market?